Nanoscope Therapeutics has released positive 3-year follow-up data from its REMAIN study, the long-term extension of the ...
SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown strong ...
The move has drawn significant criticism from a number of student groups, with CULC describing it as 'an assault on the trans ...
SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...
The finalists, 190 products spanning 32 technology categories, were selected by the CRN staff. Those products have gone into ...
Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...
History meets the 21st century in this Croatian city. You'll find many fun things to do in Zagreb both in the Lower and Upper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback